(Q54641807)

2 June 2018

title

Activin A induces a non-fibrotic phenotype in smooth muscle cells in contrast to TGF-β. (English)

1 reference

2 June 2018

author

Yolanda M Pacheco

4

1 reference

2 June 2018

author name string

Bianca C W Groenendijk

1

1 reference

2 June 2018

Germaine F J D Benus

2

1 reference

2 June 2018

Anita Klous

3

1 reference

2 June 2018

Oscar L Volger

5

1 reference

2 June 2018

Joost O Fledderus

6

1 reference

2 June 2018

Valerie Ferreira

7

1 reference

2 June 2018

Marten A Engelse

8

1 reference

2 June 2018

Hans Pannekoek

9

1 reference

2 June 2018

Peter ten Dijke

10

1 reference

2 June 2018

Anton J G Horrevoets

11

1 reference

2 June 2018

Carlie J M de Vries

12

1 reference

2 June 2018

language of work or name

English

0 references

publication date

15 October 2010

1 reference

2 June 2018

Experimental Cell Research

published in

1 reference

2 June 2018

volume

317

1 reference

2 June 2018

issue

2

1 reference

2 June 2018

page(s)

131-142

1 reference

2 June 2018

TGF-beta and atherosclerosis in man.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Roles of activin in tissue repair, fibrosis, and inflammatory disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

The transforming growth factor-beta superfamily of receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Adenoviral activin a expression prevents intimal hyperplasia in human and murine blood vessels by maintaining the contractile smooth muscle cell phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Disruption of TGF-β signaling in T cells accelerates atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

In vivo effect of TGF- beta 1. Enhanced intimal thickening by administration of TGF- beta 1 in rabbit arteries injured with a balloon catheter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Controlling cell fate by bone morphogenetic protein receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

TGF-beta receptor function in the endothelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

The activin A-follistatin system: potent regulator of human extracellular matrix mineralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Activin modulates the transcriptional response of LbetaT2 cells to gonadotropin-releasing hormone and alters cellular proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

In situ measurement of collagen synthesis by human bone cells with a sirius red-based colorimetric microassay: effects of transforming growth factor beta2 and ascorbic acid 2-phosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

TGF-beta signaling in vascular fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Expression of endoglin mRNA and protein in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Connective tissue growth factor: what's in a name?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Human connective tissue growth factor is expressed in advanced atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Inhibitory effect of activin A on activation of lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

Role of activin-A and follistatin in foam cell formation of THP-1 macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.10.007

10.1016/J.YEXCR.2010.10.007

7 January 2021

Identifiers

DOI

1 reference

2 June 2018

release_2vzlbwzravem7f6lusotentmye

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2vzlbwzravem7f6lusotentmye

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

20955695

1 reference

2 June 2018